Poolbeg Pharma PLC (AIM:POLB) is raising £4.1 million to support trials for its cancer immunotherapy and oral obesity treatments. The funds should carry it into 2027 and help reach key milestones like dosing the first phase IIa patient in its POLB 001 trial this year.
IXICO PLC (LSE:IXI, OTC:PHYOF) says it's on course to meet or beat full-year expectations after first-half revenue jumped 26% to £3.2 million. The brain imaging group credited its "Innovate, Lead, Scale" strategy and signed a new Huntington’s trial contract post-period.
ATOME PLC (AIM:ATOM) has launched a new renewables arm called ATOME Power, focused on Latin America. Its first project is a massive 400-megawatt solar and battery site in Paraguay near its green fertiliser facility in Villeta.
Caledonia Mining Corporation PLC (AIM:CMCL, NYSE-A:CMCL) has published its 2024 ESG report, outlining new steps on climate risk and long-term planning. The gold miner also installed solar power in local schools and kicked off new sustainability compliance work.
Hercules Site Services is dropping “Site Services” and rebranding as Hercules PLC (LSE:HERC). It says the name change reflects its wider focus on labour supply across UK construction and infrastructure projects.
Follow us and subscribe on YouTube, our social channels and on proactiveinvestors.co.uk.
